The 7-year-old son of Socastee High School’s head football coach is now cancer-free after battling a rare form of leukemia ...

Detailed price information for Medexus Pharmaceuticals Inc (MDP-T) from The Globe and Mail including charting and trades.

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

Exicure, Inc. (Nasdaq: XCUR) today shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. ("Exicure") is planning for a clinical trial in Acute Myeloid ...

Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to ...

Jibraan, who planned to study Theoretical Physics, was in remission from a rare and aggressive form of acute myeloid leukemia and awaiting a life-saving stem cell transplant at University Hospital ...

A pair of identical twins only four and a half years old have become China's youngest-ever hematopoietic stem cell donors, ...

"It's way more important than anything I do on the field. I love what I do on the field, but, I mean, this is what it's ...